Dr. Ai-Ja Jackson

So again, I say patients should advocate for themselves and really kind of talk with their doctor and ask the questions that they need to ask.

But also I think a lot of providers, when they diagnose a patient with say diabetes or high blood pressure or high cholesterol,

they go by the book and say, okay, this is first-line therapy.

Let me put you on this.

And sometimes that therapy does not work for the patient.

The patient has terrible side effects.

So if the patient has done a pharmacogenomics study and they say, well, actually, doc, that medication does not work well for me.

My body doesn't clear that out good enough.

These are the medications that were a pharmacist recommended, or here's the list of medications for

high cholesterol or high blood pressure that show work better for me.

I think that would help a lot of patients also and cut costs down because now they're not wasting money on trying all of these different medications and nothing's working.

And now they're going back to the doctor and back to the pharmacy.

It's like that flip-flop sometimes.

Right.

Yeah.

So for the program that I'm building, they are, it's a benefit through the members insurance.

Usually it's, it's that way.

I know there are some consumers that do have like kind of like ancestry and

they'll do like a pharmacogenomics, you can do it that way.

But a lot of it is through your insurance.